Examples
Worked examples
- Is an instance
A multi-site clinical trial publishes its primary results under a byline reading "The [Trial Name] Investigators," with the individually named site investigators and their specific roles listed in an appendix or acknowledgments section rather than the main author line -- the ICMJE-recommended pattern for large collaborative bylines.
- Is an instance
A large-scale physics or astronomy collaboration with thousands of contributing researchers (the convention used by CERN's ATLAS and CMS experiments, for example) publishes under the collaboration's own name as corporate author, with the full contributor list maintained and published separately from the article byline itself.
Counter-examples
Looks similar, but isn't
- Not an instance
A three-person research team lists each member individually by name on the byline, in contribution-ranked order, with no collective or group name appearing anywhere in the author line -- this is co-authorship, not corporate authorship, because no entity name stands in for the individuals.
Editorial commentary
Corporate authorship is authorship attributed to an organization, consortium, study group, or other collective entity rather than (or in addition to) the individually named people who did the work. A byline that reads a group’s own name — “The XYZ Consortium,” “the [Trial Name] Investigators,” “[Project] Study Group” — rather than a list of personal names is exercising corporate authorship. It sits alongside authorship and co-authorship as a third structural pattern: sole authorship is one named person, co-authorship is two or more named people, and corporate authorship substitutes a collective name for some or all of the individual names on the byline itself.
Corporate authorship vs. co-authorship
The distinction is about what the byline itself displays, not about how many people actually contributed. A ten-person research team that lists all ten names individually is exercising co-authorship, however large the group. A trial with a hundred contributing investigators that instead publishes under “The [Trial Name] Investigators” is exercising corporate authorship — the collective stands in for the roster on the byline, even though the underlying accountability requirements are identical. Corporate authorship does not remove the need for individual accountability; it changes where that individual identification is displayed (typically in an appendix, supplementary file, or acknowledgments section rather than the main byline).
What ICMJE and COPE actually require
ICMJE’s “Defining the Role of Authors and Contributors” guidance addresses group bylines directly: for a work produced by a large multi-author group using a group name, “the corresponding author should specify the group name if one exists, and clearly identify the group members who can take credit and responsibility for the work as authors.” In other words, a corporate byline is not a way to avoid the underlying authorship test — every person credited through the group still has to independently meet the same authorship criteria (typically ICMJE’s four-part test: substantial contribution, drafting or critical review, final approval, and accountability) that an individually named author would have to meet. The group name is a presentation convention on top of that test, not a substitute for it. COPE’s own authorship guidance takes the same position: contributorship and accountability have to be traceable to real, identifiable individuals even when the public-facing byline is a collective name.
How MEDLINE/PubMed indexes corporate authors
The distinction is formal enough that NLM built dedicated indexing machinery for it. MEDLINE/PubMed citations carry a separate CollectiveName element (introduced as part of the XML AuthorList schema around 2000) specifically for corporate, organizational, or group author names, as distinct from the PersonalName elements used for individually named authors. A single citation can carry both — personal author names plus one or more collective names — and NLM places collective names at the end of the personal-author list when both appear. This reflects the same real-world pattern: a paper can be co-authored by named individuals and simultaneously credited to a study group or consortium at the corporate-author level.
The broader library-science sense
Corporate authorship also has an older, broader meaning in library and information science, predating its specific use in journal bylines: any publication issued in the name of an organization — a government agency, a company, a standards body, an NGO — rather than a named person is treated as having a corporate author for cataloging and citation purposes (for example, a report cited as “World Health Organization. (2023). Report title.” rather than under a named individual). Research administrators most often encounter this sense when citing institutional reports, government data releases, or organizational policy documents rather than journal articles, but it is the same underlying concept: an entity, not a person, is the credited originator of the work.
Why the distinction matters operationally
For research administrators and authorship-policy stewards, corporate authorship raises questions individual and co-authorship don’t: who is the accountable point of contact when the byline is an entity rather than a person (typically resolved via a designated corresponding author, per ICMJE); how contributing individuals still receive citable credit despite not appearing on the main byline (contributor lists, structured contribution statements, or CRediT-style role tagging applied to the underlying roster); and how authorship disputes are resolved when the disputing parties are members of a named collective rather than individually listed co-authors. None of these are new authorship tests — they are the same accountability and contribution requirements as individual authorship, applied to a group that has chosen to present itself under a single collective name.
Machine-readable encodings
Use in your systems
<role vocab="credit"
vocab-identifier="https://casrai.org/dictionary/"
vocab-term="Corporate Authorship"
vocab-term-identifier="https://casrai.org/dictionary/term/corporate-authorship" />{
"@context": "https://schema.org",
"@type": "DefinedTerm",
"@id": "https://casrai.org/dictionary/term/corporate-authorship",
"name": "Corporate Authorship",
"identifier": "https://casrai.org/dictionary/term/corporate-authorship",
"description": "Corporate authorship is the practice of naming an organizational or collective entity -- a consortium, study group, working group, network, or corporate body -- as the author of record on a byline, in place of (or alongside) individually named researchers. It is distinguished from co-authorship by what appears on the byline itself: co-authorship is two or more named individuals who each independently meet the authorship criteria for the work, while corporate authorship substitutes or supplements those individual names with a group name that stands for the collective. The individuals who did the work still have to be identifiable and accountable -- ICMJE guidance requires the corresponding author to specify the group name and clearly identify which group members can take credit and responsibility as authors -- but the byline itself reads as the entity, not the roster.",
"inDefinedTermSet": "https://casrai.org/dictionary/domain/credit-extensions#set",
"url": "https://casrai.org/dictionary/term/corporate-authorship",
"sameAs": [],
"license": "https://creativecommons.org/licenses/by/4.0/",
"publisher": {
"@id": "https://casrai.org/#organization"
},
"dateModified": "2026-07-18T00:43:40",
"inLanguage": "en"
}






